In breast cancer, elevated OSR1 expression has been associated with unfavorable prognoses and enhanced metastatic potential of endothelial cells, potentially mediated by altered TGF-β1 secretion through phosphorylation of the Smad2/3 linker region (Li et al., 2021; Li et al., 2020). Here, OSR1 is linked to breast carcinoma.